Thomas Stricker, MD, PhD, and Gregory Vidal, MD, PhD, are both first authors on their respective abstracts involving patients with advanced non-small cell lung cancer in the community setting.
Nashville, Tennessee—OneOncology Clinical Investigators, Thomas Stricker, MD, PhD, Medical Director of Precision Medicine for OneOncology, and Gregory Vidal, MD, PhD, Chair of Breast Cancer Disease Group,
OneOncology, and Director of Clinical Research, West Cancer Center & Research Institute, are each the first authors on 2 abstracts accepted for oral presentation at the 2023 Annual Meeting of the American Society of Clinical Oncology. Both will present their abstracts during the June 6 session from 8 a.m. to 11 a.m.
Stricker is the first author of Abstract 6507, “Clinical Value of Timely Treatment for Advanced Non-Small Cell Lung Cancer Patients (aNSCLC) with Actionable Driver OncoGenes.”
Vidal is the first author of Abstract 6508, “Practice-and Provider-Level Inequities in Next-Generation Sequencing Testing by Race/Ethnicity for Patients with aNSCLC in the Community Setting.”
“OneOncology’s clinical research team and our partners will unveil insightful and actionable NGS-testing research that can advance better health outcomes and improve health equity,” said Davey Daniel, MD., OneOncology Chief Medical Officer.
Both studies were conducted with Genentech, a member of the Roche Group, as part of a multi-year strategic partnership to collaborate on various clinical trials, scientific research, and real-world data studies advancing personalized cancer care in community oncology centers.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen